Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Synthesis, Biological Activity, and Molecular Modelling Studies of Naphthoquinone Derivatives as Promising Anticancer Candidates Targeting COX-2.
Pharmaceuticals (Basel). 2022 Apr 27;15(5):541. doi: 10.3390/ph15050541.
Pharmaceuticals (Basel). 2022.
PMID: 35631366
Free PMC article.
Characterization of ribonucleotide reductases of emerging pathogens Elizabethkingia anophelis and Elizabethkingia meningoseptica and streptonigrin as their inhibitor: a computational study.
Mahfuz AMUB, Iqbal MN, Opazo FS, Zubair-Bin-Mahfuj AM.
Mahfuz AMUB, et al. Among authors: opazo fs.
J Biomol Struct Dyn. 2022;40(19):9509-9521. doi: 10.1080/07391102.2021.1930166. Epub 2021 May 28.
J Biomol Struct Dyn. 2022.
PMID: 34048660
Item in Clipboard
Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of Klebsiella pneumoniae and Mycobacterium tuberculosis as a drug target enzyme: insights from molecular docking and molecular dynamics.
Mahfuz AMUB, Stambuk Opazo F, Aguilar LF, Iqbal MN.
Mahfuz AMUB, et al. Among authors: stambuk opazo f.
J Biomol Struct Dyn. 2022 Jun;40(9):4021-4037. doi: 10.1080/07391102.2020.1852966. Epub 2020 Nov 30.
J Biomol Struct Dyn. 2022.
PMID: 33251968
Item in Clipboard
Cite
Cite